Potential Mechanism of Platelet GPIIb/IIIa and Fibrinogen on Retinal Vein Occlusion

References

• Coscas G, Loewenstein A, Augustin A, Bandello F, Battaglia Parodi M, Lanzetta P, Monés J, de Smet M, Soubrane G, Staurenghi G. Management of retinal vein occlusion–consensus document. Ophthalmologica. 2011;226(1):4–28. doi: 10.1159/000327391.
   PubMed Web of Science ®Google Scholar
• Weinstein O, Kridin M, Kridin K, Mann O, Cohen AD, Zloto O. The risk of retinal vein occlusion among patients with neovascular age related macular degeneration: a large-scale cohort study. Eye (Lond)). 2023;37(7):1445–1450. doi: 10.1038/s41433-022-02163-7.
   PubMed Web of Science ®Google Scholar
• Bertelmann T, Sekundo W, Strodthoff S, Witteborn MC, Stief T, Irle S, Nguyen N, Koss MJ, Mennel S. Intravitreal functional plasminogen in eyes with branch retinal vein occlusion. Ophthalmic Res. 2014;52(2):74–80. doi: 10.1159/000362340.
   PubMed Web of Science ®Google Scholar
• Marcinkowska A, Cisiecki S, Rozalski M. Platelet and thrombophilia-related risk factors of retinal vein occlusion. J Clin Med. 2021;10(14):3080. doi: 10.3390/jcm10143080.
   PubMed Web of Science ®Google Scholar
• Bertelmann T, Stief T, Sekundo W, Witteborn M, Strodthoff S, Mennel S, Nguyen N, Koss M. Intravitreale Fibrinolyse und retinaler Venenverschluss [Intravitreal fibrinolysis and retinal vein occlusion]. Ophthalmologe. 2015;112(2):155–161. doi: 10.1007/s00347-014-3107-z.
   PubMed Web of Science ®Google Scholar
• Ghazi NG, Noureddine B, Haddad RS, Jurdi FA, Bashshur ZF. Intravitreal tissue plasminogen activator in the management of central retinal vein occlusion. Retina. 2003;23(6):780–784. doi: 10.1097/00006982-200312000-00006.
   PubMed Web of Science ®Google Scholar
• Kumagai K, Tsujikawa A, Muraoka Y, Akagi-Kurashige Y, Murakami T, Miyamoto K, Yamada R, Yoshimura N. Three-dimensional optical coherence tomography evaluation of vascular changes at arteriovenous crossings. Invest Ophthalmol Vis Sci. 2014;55(3):1867–1875. doi: 10.1167/iovs.13-13303.
   PubMed Web of Science ®Google Scholar
• Yilmaz T, Yilmaz A. Altered platelet morphological parameters in patients with retinal vein occlusion. Eur Rev Med Pharmacol Sci. 2016;20(10):1934–1939.
   PubMed Web of Science ®Google Scholar
• Ulutas KT, Dokuyucu R, Sefil F, Yengil E, Sumbul AT, Rizaoglu H, Ustun I, Yula E, Sabuncu T, Gokce C. Evaluation of mean platelet volume in patients with type 2 diabetes mellitus and blood glucose regulation: a marker for atherosclerosis? Int J Clin Exp Med. 2014;7(4):955–961.
   PubMed Web of Science ®Google Scholar
• Liu Z, Perry LA, Penny-Dimri JC, Raveendran D, Hu ML, Arslan J, Britten-Jones AC, O'Hare F, Ayton LN, Edwards TL. The association of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio with retinal vein occlusion: a systematic review and meta-analysis. Acta Ophthalmol. 2022;100(3):e635–e647. doi: 10.1111/aos.14955.
   PubMed Web of Science ®Google Scholar
• Marcinkowska A, Wolska N, Luzak B, Cisiecki S, Marcinkowski K, Rozalski M. Platelet-derived procoagulant microvesicles are elevated in patients with retinal vein occlusion (RVO). J Clin Med. 2022;11(17):5099. doi: 10.3390/jcm11175099.
   PubMed Web of Science ®Google Scholar
• Barikian A, Mahfoud Z, Abdulaal M, Safar A, Bashshur ZF. Induction with intravitreal bevacizumab every two weeks in the management of neovascular age-related macular degeneration. Am J Ophthalmol. 2015;159(1):131–137. doi: 10.1016/j.ajo.2014.10.005.
   PubMed Web of Science ®Google Scholar
• Mushiga Y, Nagai N, Ozawa Y. Retinal circulation time/arm-to-retina time ratio in the fluorescein angiography to evaluate retina-specific hemodynamics. Sci Rep. 2022;12(1):17457. doi: 10.1038/s41598-022-21117-3.
   PubMed Web of Science ®Google Scholar
• Lee W, Kim JH, Lee S, Kim K, Kang TS, Han YS. Estimation of best corrected visual acuity based on deep neural network. Sci Rep. 2022;12(1):17808. doi: 10.1038/s41598-022-22586-2.
   PubMed Web of Science ®Google Scholar
• Allingham MJ, Tserentsoodol N, Saloupis P, Mettu PS, Cousins SW. Aldosterone exposure causes increased retinal edema and severe retinopathy following laser-induced retinal vein occlusion in mice. Invest Ophthalmol Vis Sci. 2018;59(8):3355–3365. doi: 10.1167/iovs.17-23073.
   PubMed Web of Science ®Google Scholar
• Zhang H, Sonoda KH, Qiao H, Oshima T, Hisatomi T, Ishibashi T. Development of a new mouse model of branch retinal vein occlusion and retinal neovascularization. Jpn J Ophthalmol. 2007;51(4):251–257. doi: 10.1007/s10384-007-0445-2.
   PubMed Web of Science ®Google Scholar
• Li T-T, Fan M-L, Hou S-X, Li X-Y, Barry DM, Jin H, Luo S-Y, Kong F, Lau L-F, Dai X-R, et al. A novel snake venom-derived GPIb antagonist, anfibatide, protects mice from acute experimental ischaemic stroke and reperfusion injury. Br J Pharmacol. 2015;172(15):3904–3916. doi: 10.1111/bph.13178.
   PubMed Web of Science ®Google Scholar
• Avrutsky MI, Ortiz CC, Johnson KV, Potenski AM, Chen CW, Lawson JM, White AJ, Yuen SK, Morales FN, Canepa E, et al. Author correction: endothelial activation of caspase-9 promotes neurovascular injury in retinal vein occlusion. Nat Commun. 2020;11(1):3502. doi: 10.1038/s41467-020-17476-y.
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Kamei M, Kunavisarut P, Suzuki M, Tano Y. Increased retinal toxicity of intravitreal tissue plasminogen activator in a central retinal vein occlusion model. Graefes Arch Clin Exp Ophthalmol. 2008;246(4):509–514. doi: 10.1007/s00417-007-0670-x.
   PubMed Web of Science ®Google Scholar
• Tejedor J, de la Villa P. Refractive changes induced by form deprivation in the mouse eye. Invest Ophthalmol Vis Sci. 2003;44(1):32–36. doi: 10.1167/iovs.01-1171.
   PubMed Web of Science ®Google Scholar
• Bucciarelli P, Passamonti SM, Gianniello F, Artoni A, Martinelli I. Thrombophilic and cardiovascular risk factors for retinal vein occlusion. Eur J Intern Med. 2017;44:44–48. doi: 10.1016/j.ejim.2017.06.022.
   PubMed Web of Science ®Google Scholar
• Huang J, Li X, Shi X, Zhu M, Wang J, Huang S, Huang X, Wang H, Li L, Deng H, et al. Platelet integrin αIIbβ3: signal transduction, regulation, and its therapeutic targeting. J Hematol Oncol. 2019;12(1):26. doi: 10.1186/s13045-019-0709-6.
   PubMedGoogle Scholar
• Vyas SP, Vaidya B. Targeted delivery of Thrombolytic Agents: role of integrin receptors. Expert Opin Drug Deliv. 2009;6(5):499–508. doi: 10.1517/17425240902878002.
   PubMed Web of Science ®Google Scholar
• Chung TL, Pumplin DW, Holton LH, 3rd, Taylor JA, Rodriguez ED, Silverman RP. Prevention of microsurgical anastomotic thrombosis using aspirin, heparin, and the glycoprotein IIb/IIIa inhibitor tirofiban. Plast Reconstr Surg. 2007;120(5):1281–1288. doi: 10.1097/01.prs.0000279327.75083.ae.
   PubMed Web of Science ®Google Scholar
• Glacet-Bernard A, Kuhn D, Vine AK, Oubraham H, Coscas G, Soubrane G. Treatment of recent onset central retinal vein occlusion with intravitreal tissue plasminogen activator: a pilot study. Br J Ophthalmol. 2000;84(6):609–613. doi: 10.1136/bjo.84.6.609.
   PubMed Web of Science ®Google Scholar
• Elman MJ, Raden RZ, Carrigan A. Intravitreal injection of tissue plasminogen activator for central retinal vein occlusion. Trans Am Ophthalmol Soc. 2001;99:219. discussion 222. doi: 10.1097/00006982-200306000-00045.
   PubMedGoogle Scholar
• Elman MJ. Thrombolytic therapy for central retinal vein occlusion: results of a pilot study. Trans Am Ophthalmol Soc. 1996;94:471–504.
   PubMedGoogle Scholar
• Murray PI, Young DW, Aggarwal RK, Blann AD. Von Willebrand factor, endothelial damage and ocular disease. Ocul Immunol Inflamm. 1993;1(4):315–322. doi: 10.3109/09273949309057058.
   PubMedGoogle Scholar
• Boyd S, Owens D, Gin T, Bunce K, Sherafat H, Perry D, Hykin PG. Plasma homocysteine, methylene tetrahydrofolate reductase C677T and factor II G20210A polymorphisms, factor VIII, and VWF in central retinal vein occlusion. Br J Ophthalmol. 2001;85(11):1313–1315. doi: 10.1136/bjo.85.11.1313.
   PubMed Web of Science ®Google Scholar
• Ishibazawa A, Nagaoka T, Takahashi T, Yamamoto K, Kamiya A, Ando J, Yoshida A. Effects of shear stress on the gene expressions of endothelial nitric oxide synthase, endothelin-1, and thrombomodulin in human retinal microvascular endothelial cells. Invest Ophthalmol Vis Sci. 2011;52(11):8496–8504. doi: 10.1167/iovs.11-7686.
   PubMed Web of Science ®Google Scholar
• Wu Y, Qiao Y, Zhang Y, Li Q, Zhang W. Trimester-specific reference intervals of TAT, TM, tPAI-C and PIC for healthy Chinese pregnant women. J Obstet Gynaecol Res. 2021;47(1):368–374. doi: 10.1111/jog.14536.
   PubMed Web of Science ®Google Scholar
• Ren W, Zhang J, Chen Y, Wen M, Su Y, Zhao Y, Lu S, Wu J. Evaluation of coagulation, fibrinolysis and endothelial biomarkers in cirrhotic patients with or without portal venous thrombosis. Clin Appl Thromb Hemost. 2020;26:1076029620982666. doi: 10.1177/1076029620982666.
   Web of Science ®Google Scholar
• Ding S, Lin Q, Zhu T, Li T, Zhu L, Wang J, Zhang X. Is there a correlation between inflammatory markers and coagulation parameters in women with advanced ovarian endometriosis? BMC Womens Health. 2019;19(1):169.
   PubMed Web of Science ®Google Scholar
• Wu Y, Zhang MH, Xue Y, Zhang T, Wu N, Guo W, Du X, Xu YL. Effect of microRNA-26a on vascular endothelial cell injury caused by lower extremity ischemia-reperfusion injury through the AMPK pathway by targeting PFKFB3. J Cell Physiol. 2019;234(3):2916–2928. doi: 10.1002/jcp.27108.
   PubMed Web of Science ®Google Scholar
• Ring CP, Pearson TC, Sanders MD, Wetherley-Mein G. Viscosity and retinal vein thrombosis. Br J Ophthalmol. 1976;60(6):397–410. doi: 10.1136/bjo.60.6.397.
   PubMed Web of Science ®Google Scholar
• Lip PL, Blann AD, Jones AF, Lip GY. Abnormalities in haemorheological factors and lipoprotein (a) in retinal vascular occlusion: implications for increased vascular risk. Eye (Lond)). 1998;12 (Pt 2) (2):245–251. doi: 10.1038/eye.1998.58.
   PubMedGoogle Scholar
• Cehofski LJ, Kojima K, Terao N, Kitazawa K, Thineshkumar S, Grauslund J, Vorum H, Honoré B. Aqueous fibronectin correlates with severity of macular edema and visual acuity in patients with branch retinal vein occlusion: a proteome study. Invest Ophthalmol Vis Sci. 2020;61(14):6. doi: 10.1167/iovs.61.14.6.
   PubMed Web of Science ®Google Scholar
• Cehofski LJ, Kojima K, Kusada N, Rasmussen M, Muttuvelu DV, Grauslund J, Vorum H, Honoré B. Macular edema in central retinal vein occlusion correlates with aqueous fibrinogen alpha chain. Invest Ophthalmol Vis Sci. 2023;64(2):23. doi: 10.1167/iovs.64.2.23.
   PubMed Web of Science ®Google Scholar
• Imai H, Otsuka K, Tetsumoto A, Miki A, Nakamura M. Effectiveness of en bloc removal of fibrinogen-rich component of cystoid lesion for the treatment of cystoid macular edema. Retina. 2020;40(1):154–159. doi: 10.1097/IAE.0000000000002359.
   PubMed Web of Science ®Google Scholar
• Li H, Cai E, Cheng H, Ye X, Ma R, Zhu H, Chang X. FGA controls VEGFA secretion to promote angiogenesis by activating the VEGFR2-FAK signalling pathway. Front Endocrinol (Lausanne)). 2022;13:791860. doi: 10.3389/fendo.2022.791860.
   PubMed Web of Science ®Google Scholar
• Klajmon A, Chmiel J, Ząbczyk M, Pociask E, Wypasek E, Malinowski KP, Undas A, Natorska J. Fibrinogen β chain and FXIII polymorphisms affect fibrin clot properties in acute pulmonary embolism. Eur J Clin Invest. 2022;52(4):e13718. doi: 10.1111/eci.13718.
   PubMed Web of Science ®Google Scholar
• Szelenberger R, Kacprzak M, Bijak M, Saluk-Bijak J, Zielinska M. Blood platelet surface receptor genetic variation and risk of thrombotic episodes. Clin Chim Acta. 2019;496:84–92. doi: 10.1016/j.cca.2019.06.020.
   PubMed Web of Science ®Google Scholar
• Todinova S, Komsa-Penkova R, Krumova S, Taneva SG, Golemanov G, Georgieva G, Tonchev P, Tsankov B, Beshev L, Balashev K, et al. PlA2 polymorphism in glycoprotein IIb/IIIa modulates the morphology and nanomechanics of platelets. Clin Appl Thromb Hemost. 2017;23(8):951–960. doi: 10.1177/1076029616687847.
   PubMed Web of Science ®Google Scholar
• Wang W, Yang L, Song L, Guo M, Li C, Yang B, Wang M, Kou N, Gao J, Qu H, et al. Combination of panax notoginseng saponins and aspirin potentiates platelet inhibition with alleviated gastric injury via modulating arachidonic acid metabolism. Biomed Pharmacother. 2021;134:111165. doi: 10.1016/j.biopha.2020.111165.
   PubMed Web of Science ®Google Scholar
• Yuan YZ, Yuan F, Xu QY, Yu J, Li L, Zhang JL. Effect of Fufang Xueshuantong Capsule on a rat model of retinal vein occlusion. Chin J Integr Med. 2011;17(4):296–301. doi: 10.1007/s11655-011-0690-6.
   PubMed Web of Science ®Google Scholar
• Darkovska-Serafimovska M, Janevik-Ivanovska E, Djorgoski I, Arsova-Sarafinovska Z, Zdravkovska M, Balkanov T, Ugresic N. Radiolabeled tirofiban - a potential radiopharmaceutical for detection of deep venous thrombosis. Drug Des Devel Ther. 2016;10:2989–2996. doi: 10.2147/DDDT.S112366.
   PubMed Web of Science ®Google Scholar
• Ha K, Zheng X, Kessinger CW, Mauskapf A, Li W, Kawamura Y, Orii M, Hilderbrand SA, Jaffer FA, McCarthy JR. In vivo platelet detection using a glycoprotein IIb/IIIa-targeted near-infrared fluorescence imaging probe. ACS Sens. 2021;6(6):2225–2232. doi: 10.1021/acssensors.1c00124.
   PubMed Web of Science ®Google Scholar
• Nicholson L, Talks SJ, Amoaku W, Talks K, Sivaprasad S. Retinal vein occlusion (RVO) guideline: executive summary. Eye (Lond)). 2022;36(5):909–912. doi: 10.1038/s41433-022-02007-4.
   PubMed Web of Science ®Google Scholar
• Romano F, Lamanna F, Gabrielle PH, Teo KYC, Battaglia Parodi M, Iacono P, Fraser-Bell S, Cornish EE, Nassisi M, Viola F, et al. Update on retinal vein occlusion. Asia Pac J Ophthalmol (Phila)). 2023;12(2):196–210. doi: 10.1097/APO.0000000000000598.
   PubMed Web of Science ®Google Scholar
• McAllister IL. Chorioretinal anastomosis for central retinal vein occlusion: a review of its development, technique, complications, and role in management. Asia Pac J Ophthalmol (Phila)). 2020;9(3):239–249. doi: 10.1097/APO.0000000000000286.
   PubMed Web of Science ®Google Scholar
• Weiss JN, Bynoe LA. Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion. Ophthalmology. 2001;108(12):2249–2257. doi: 10.1016/s0161-6420(01)00875-2.
   PubMed Web of Science ®Google Scholar
• García-Arumí J, Martinez-Castillo V, Boixadera A, Blasco H, Corcostegui B. Management of macular edema in branch retinal vein occlusion with sheathotomy and recombinant tissue plasminogen activator. Retina. 2004;24(4):530–540. doi: 10.1097/00006982-200408000-00005.
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhang Y, Tang X, Su W, Yang C, Pan D, Zhao D, Qi B, Li X. Hemostatic effect of 20(S)-panaxadiol by induced platelet aggregation depending on calcium signaling pathway. Biomed Res Int. 2022; 20222022:8265898. doi: 10.1155/2022/8265898.
   PubMed Web of Science ®Google Scholar
• Morris SM, Chauhan A. The role of platelet mediated thromboinflammation in acute liver injury. Front Immunol. 2022;13:1037645. doi: 10.3389/fimmu.2022.1037645.
   PubMed Web of Science ®Google Scholar
• von Brühl ML, Stark K, Steinhart A, Chandraratne S, Konrad I, Lorenz M, Khandoga A, Tirniceriu A, Coletti R, Köllnberger M, et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med. 2012;209(4):819–835. doi: 10.1084/jem.20112322.
   PubMed Web of Science ®Google Scholar
• Wilson CA, Hatchell DL. Photodynamic retinal vascular thrombosis. Rate and duration of vascular occlusion. Invest Ophthalmol Vis Sci. 1991;32(8):2357–2365.
   PubMed Web of Science ®Google Scholar
• Green WR, Chan CC, Hutchins GM, Terry JM. Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Retina. 2005;25 (5 Suppl):27–55. doi: 10.1097/00006982-200507001-00008.
   PubMed Web of Science ®Google Scholar
• Arroyo JG, Dastgheib K, Hatchell DL. Antithrombotic effect of ticlopidine in an experimental model of retinal vein occlusion. Jpn J Ophthalmol. 2001;45(4):359–362. doi: 10.1016/s0021-5155(01)00337-9.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Fortune B, Atchaneeyasakul LO, McFarland T, Mose K, Wallace P, Main J, Wilson D, Appukuttan B, Stout JT. Natural history and histology in a rat model of laser-induced photothrombotic retinal vein occlusion. Curr Eye Res. 2008;33(4):365–376. doi: 10.1080/02713680801939318.
   PubMed Web of Science ®Google Scholar